ALKS vs AMRN: Side-by-Side Comparison
Compare Alkermes plc (ALKS) and Amarin Corp (AMRN) side by side: market cap USD 9.10B vs USD 343.26M. Financials, growth and model signals on Bullrun.
| Metric | ALKS | AMRN |
|---|---|---|
| Company | Alkermes plc | Amarin Corp |
| Country / Exchange | Ireland · NASDAQ | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic | Drug Manufacturers-General |
| Market cap | USD 9.10B | USD 343.26M |
| P/E ratio | 60.7 | — |
| Dividend yield | — | — |
| Valuation model | 51.7% overvalued | — |
| Revenue (FY2025) | USD 1.48B | USD 213.65M |
| Revenue growth YoY | -5.2% | -6.5% |
| Net income | USD 241.70M | USD -38.80M |
| Gross margin | 86.7% | 56.6% |
| Diluted EPS | 1.43 | -0.09 |